{
  "paper_metadata": {
    "pmid": "30275862",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the BRCA2 variant c.849dupT, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.849dupT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female patient",
        "phenotype": "familial breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 1,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "familial breast cancer",
          "evidence_sentence": "A novel mutation (c.849dupT) in BRCA2 was identified in a female patient and her unaffected brothers."
        },
        {
          "individual_id": "Brother_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": null,
          "evidence_sentence": "A novel mutation (c.849dupT) in BRCA2 was identified in a female patient and her unaffected brothers."
        },
        {
          "individual_id": "Brother_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": null,
          "evidence_sentence": "A novel mutation (c.849dupT) in BRCA2 was identified in a female patient and her unaffected brothers."
        }
      ],
      "functional_data": {
        "summary": "This mutation leads to the truncation of BRCA2 functional domains and significantly reduces BRCA2 mRNA expression levels.",
        "assays": [
          "immunofluorescence",
          "western blot"
        ]
      },
      "segregation_data": "This mutation is strongly associated with familial breast cancer.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 1",
      "additional_notes": "The effects of this BRCA2 mutation on drug resistance should be taken into consideration during treatment.",
      "key_quotes": [
        "This mutation leads to the truncation of BRCA2 functional domains.",
        "BRCA2 mRNA expression levels in mutation carriers are significantly reduced compared to noncarriers."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}